Virology · 2011
Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ssemwanga Deogratius, Lyagoba Frederick, Ndembi Nicaise, Mayanja Billy N, Larke Natasha, Wang Shuyi, Baalwa Joshua, Williamson Carolyn, Grosskurth Heiner, Kaleebu Pontiano
Аннотация
We report on the frequency of multiple infections, generation of recombinants and consequences on disease progression in 35 HIV-1 infected individuals from 7 monogamous and 6 polygamous partnerships within a Rural Clinical Cohort in Uganda. The env-C2V3, gag-p24 and pol-IN genes were sequenced. Single genome amplified half genome sequences were used to map recombination breakpoints. Three participants were dually infected with subtypes A and D, one case with subtype A and A/D recombinant and the fifth with 2 phylogenetically distinct A/D recombinants. Occurrence of A/D recombination was observed in two multiple infected individuals. Rate of late stage WHO events using Cox regression was 3 times greater amongst multiple infected compared to singly infected individuals (hazard ratio 3.35; 95% CI 1.09, 10.3; p=0.049). We have shown that polygamous relationships involving subtype discordant partnerships was a major contributor of multiple infections with generation of inter subtype recombinants in our cohort.
Предметные рубрики MeSH
AdultAmbulatory Care FacilitiesCluster AnalysisCohort StudiesFemaleGenotypeHIV InfectionsHIV-1HeterosexualityHumansMaleMolecular Sequence DataRecombination, GeneticRural PopulationSequence Analysis, DNAUgandaenv Gene Products, Human Immunodeficiency Virusgag Gene Products, Human Immunodeficiency Viruspol Gene Products, Human Immunodeficiency Virus